These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 11217918)
1. Comparative molecular field analysis (coMFA) study of epothilones-tubulin depolymerization inhibitors: pharmacophore development using 3D QSAR methods. Lee KW; Briggs JM J Comput Aided Mol Des; 2001 Jan; 15(1):41-55. PubMed ID: 11217918 [TBL] [Abstract][Full Text] [Related]
2. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents. Ahmadi S; Habibpour E Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182 [TBL] [Abstract][Full Text] [Related]
3. 3D QSAR studies of the interaction between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones. Manetti F; Forli S; Maccari L; Corelli F; Botta M Farmaco; 2003 May; 58(5):357-61. PubMed ID: 12729829 [TBL] [Abstract][Full Text] [Related]
4. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations. Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912 [TBL] [Abstract][Full Text] [Related]
5. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884 [TBL] [Abstract][Full Text] [Related]
6. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4. Gaurav A; Singh R Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782 [TBL] [Abstract][Full Text] [Related]
7. 3D QSAR models of interactions between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones. Manetti F; Maccari L; Corelli F; Botta M Curr Top Med Chem; 2004; 4(2):203-17. PubMed ID: 14754454 [TBL] [Abstract][Full Text] [Related]
8. Identification of Essential 2D and 3D Chemical Features for Discovery of the Novel Tubulin Polymerization Inhibitors. Azimi F; Ghasemi JB; Saghaei L; Hassanzadeh F; Mahdavi M; Sadeghi-Aliabadi H; Scotti MT; Scotti L Curr Top Med Chem; 2019; 19(13):1092-1120. PubMed ID: 31109275 [TBL] [Abstract][Full Text] [Related]
9. QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents. Habibpour E; Ahmadi S Curr Comput Aided Drug Des; 2017; 13(2):143-159. PubMed ID: 28120704 [TBL] [Abstract][Full Text] [Related]
10. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. Hou T; Zhu L; Chen L; Xu X J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic insights into mode of action of novel natural cathepsin L inhibitors. Tyagi C; Grover S; Dhanjal J; Goyal S; Goyal M; Grover A BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S10. PubMed ID: 24564425 [TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity. Mirzaei S; Ghodsi R; Hadizadeh F; Sahebkar A Biomed Res Int; 2021; 2021():6480804. PubMed ID: 34485522 [TBL] [Abstract][Full Text] [Related]
13. A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors. Xie H; Chen L; Zhang J; Xie X; Qiu K; Fu J Int J Mol Sci; 2015 May; 16(6):12307-23. PubMed ID: 26035757 [TBL] [Abstract][Full Text] [Related]
14. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors. Xie H; Qiu K; Xie X Int J Mol Sci; 2014 Nov; 15(11):20927-47. PubMed ID: 25405729 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of novel epothilone analogues by means of a common pharmacophore and a QSAR pseudoreceptor model for taxanes and epothilones. Forli S; Manetti F; Altmann KH; Botta M ChemMedChem; 2010 Jan; 5(1):35-40. PubMed ID: 19904799 [No Abstract] [Full Text] [Related]
16. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models. Bhongade BA; Gadad AK J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035 [TBL] [Abstract][Full Text] [Related]
17. QNA-based 'Star Track' QSAR approach. Filimonov DA; Zakharov AV; Lagunin AA; Poroikov VV SAR QSAR Environ Res; 2009 Oct; 20(7-8):679-709. PubMed ID: 20024804 [TBL] [Abstract][Full Text] [Related]
18. Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors. Liao SY; Chen JC; Miao TF; Shen Y; Zheng KC J Enzyme Inhib Med Chem; 2010 Jun; 25(3):421-9. PubMed ID: 19874191 [TBL] [Abstract][Full Text] [Related]
19. Molecular modeling and structure-activity relationship of podophyllotoxin and its congeners. Naik PK; Alam A; Malhotra A; Rizvi O J Biomol Screen; 2010 Jun; 15(5):528-40. PubMed ID: 20460251 [TBL] [Abstract][Full Text] [Related]
20. Four-dimensional quantitative structure-activity relationship analysis of a series of interphenylene 7-oxabicycloheptane oxazole thromboxane A2 receptor antagonists. Albuquerque MG; Hopfinger AJ; Barreiro EJ; de Alencastro RB J Chem Inf Comput Sci; 1998; 38(5):925-38. PubMed ID: 9770304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]